Extended Data Fig. 7: Schematics of the between-group and within-group analysis of TCGA untreated samples.
From: MHC II immunogenicity shapes the neoepitope landscape in human tumors
In the between-group analysis, the samples are divided into high-and low-immune groups, and the corresponding group’s VAF difference was calculated for immunogenic and nonimmunogenic mutations. For the within-group analysis, VAF differences between immunogenic and nonimmunogenic mutations were calculated for each high-and low-immune group.
